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Abstract
Introduction:  Erectile  dysfunction  (ED)  is  one  of  the  most  prevalent  male  sexual  disorders  world-
wide. When  conservative  treatment  is  unsuccessful,  contraindicated  or  causes  unacceptable
side effects  penile  prosthesis  implantation  is  a  deﬁnitive  option  for  the  management  of  ED.
Although considered  a  third-line  therapy,  it  achieves  the  highest  satisfaction  rates  as  com-
pared with  non-surgical  treatment.  Three-piece  inﬂatable  penile  prothesis  (IPP)  represents  the
most sophisticated  implantable  device,  AMS  700CXTM and  Coloplast  Titan
®
being  the  two  most
commonly  used.  Although  there  are  several  studies  evaluating  patient  satisfaction  with  either
model, there  is  little  published  data  comparing  both  models.
Methods:  We  have  compared  overall  patient  satisfaction  in  55  patients  submitted  to  either
700CXTM or  Titan
®
implantation.  The  Erectile  Dysfunction  Inventory  of  Treatment  Satisfaction
(EDITS) questionnaire  was  used  to  access  patient  satisfaction.
Results:  Patient  mean  age  and  follow-up  time  were  59.1  years  and  57.9  months  respectively.
There was  no  difference  in  EDITS  score  between  700CXTM and  Titan
®
IPP  (77.2  ±  12.1  versus
77.5 ±  16.6  respectively,  p  =  0.956).
Conclusion:  Overall  patient  satisfaction  as  assessed  by  EDITS  questionnaire  was  not  different
between 700CXTM and  Titan
®
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Satisfacción  a  largo  plazo  reportada  por  el  paciente  con  diferentes  prótesis  de  pene
inﬂables:  comparación  entre  AMS  700CX  y  Coloplast  Titan
Resumen
Introducción:  La  disfunción  eréctil  (DE)  constituye  uno  de  los  trastornos  sexuales  masculinos
con mayor  prevalencia  a  nivel  mundial.  Cuando  el  tratamiento  conservador  es  infructuoso,  está
contraindicado,  o  causa  efectos  colaterales  inaceptables,  la  implantación  de  prótesis  de  pene
es una  opción  deﬁnitiva  para  el  tratamiento  de  la  DE.  Aunque  es  considerada  una  terapia  de
tercera línea,  alcanza  unas  tasas  de  satisfacción  superiores  en  comparación  con  el  tratamiento
no quirúrgico.  La  prótesis  de  pene  inﬂable  de  3  piezas  (IPP)  constituye  el  dispositivo  implantable
más soﬁsticado,  siendo  AMS  700CXTM y  Coloplast  Titan
®
los  2  dispositivos  más  comúnmente
utilizados.  Aunque  existen  diversos  estudios  que  evalúan  la  satisfacción  del  paciente  con  cada
uno de  los  modelos,  existen  pocos  datos  publicados  que  comparen  ambos.
Métodos:  Comparamos  la  satisfacción  general  del  paciente  en  55  individuos  a  los  que  se  realizó
implantación  de  700CXTM o  Titan
®
.  Se  utilizó  el  cuestionario  Erectile  Dysfunction  Inventory  of
Treatment Satisfaction  (EDITS)  para  valorar  la  satisfacción  del  paciente.
Resultados:  La  edad  media  de  los  pacientes  y  el  tiempo  de  seguimiento  fueron  de  59,1  an˜os  y
57,9 meses,  respectivamente.  No  se  encontró  diferencia  alguna  en  cuanto  a  puntuación  EDITS
entre los  IPP  700CXTM y  Titan
®
(77,2  ±  12,1  frente  a  77,5  ±  16,6,  respectivamente;  p  =  0,956).
Conclusiones:  La  satisfacción  general  del  paciente,  evaluada  mediante  el  cuestionario  EDITS,
no arrojó  diferencias  entre  700CXTM y  Titan
®
.
© 2017  Asociacio´n  Espan˜ola  de  Androlog´ıa,  Medicina  Sexual  y  Reproductiva.  Publicado  por
Elsevier Espan˜a,  S.L.U.  Todos  los  derechos  reservados.
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rectile  dysfunction  (ED)  is  deﬁned  as  the  consistent
r  recurrent  inability  of  man  to  achieve  and/or  main-
ain  an  erection  sufﬁcient  to  permit  satisfactory  sexual
erformance.1 ED  affects  physical  and  psychosocial  health
nd  may  substantially  decrease  the  quality  of  life  of  suf-
erers  and  their  partners.2 It  is  one  of  the  most  common
ale  sexual  disorders  worldwide.3 A  large  community-based
tudy  that  included  adult  men,  aged  20--75  years,  from  eight
ifferent  countries  has  reported  an  overall  ED  prevalence
ate  of  16%.  ED’s  prevalence  increases  with  aging  and  is
stimated  to  be  at  its  highest  in  men  aged  70--75  years
37%).4
Only  few  causes  of  ED  have  the  potential  to  be  cured  by
 cause-speciﬁc  treatment.  Most  men  with  ED  are  treated
ith  methods  to  achieve  erection,  regardless  of  its  cause.
t  present,  phosphodiesterase  type  5  inhibitors  (PDE5-I)  are
he  treatment  of  choice  for  the  majority  of  patients,  regard-
ess  of  the  underlying  ED  etiology.5,6 The  introduction  of
DE5-I  in  1998  has,  indeed,  revolutionized  the  management
f  ED,  because  of  their  efﬁcacy,  acceptance  and  safety.  How-
ver,  between  30%  and  40%  of  ED  patients  do  not  respond
o  PDE5-I.5 Patients  who  do  not  respond  to  oral  drug  ther-
py  and  those  who  cannot  tolerate  or  use  PDE5-I  because
f  speciﬁc  contraindications  may  be  given  the  option  to  be
reated  with  either  intracavernosal  or  intraurethral  medical
herapy,  or  with  a  vacuum  constrictor  device,5,6 which  arePlease  cite  this  article  in  press  as:  Morgado  A,  et  al.
ent  inﬂatable  penile  prosthesis:  Comparison  between  AM
http://dx.doi.org/10.1016/j.androl.2017.07.003
ffective  for  most  causes  of  ED.  However,  they  tend  to  have
igh  dropout  rates.7,8 In  cases  where  conservative  treatment
s  unsuccessful,  contraindicated  or  causes  unacceptable  side
ffects,  penile  prosthesis  implantation  is  a  deﬁnitive  option
s
w
lor  the  management  of  ED.  Although  considered  a  third-
ine  therapy,5,6 when  properly  selected,  penile  prosthesis
mplantation  achieves  the  highest  satisfaction  rates,  as  com-
ared  with  non-surgical  treatments.9,10
Currently  available  penile  prostheses  can  broadly  be
ivided  into  semi-rigid  and  inﬂatable  devices.  Inﬂatable
mplants  include  two  and  three  piece  prosthesis.11,12 Hav-
ng  evolved  from  malleable  and  two-piece  inﬂatable  penile
mplants,  the  three-piece  inﬂatable  penile  prothesis  (IPP)
epresent  the  most  sophisticated  implantable  device  with
he  highest  patient-reported  satisfaction  rates.13 Although
here  are  several  brands  and  models  of  inﬂatable  three-
iece  IPP  the  two  most  commonly  used  models  are
00CXTM (AMS;  American  Medical  Systems  Inc.,  Minneapo-
is,  MN,  USA)  and  Titan
®
(Coloplast  Corp.,  Minneapolis,  MN,
SA).  Several  studies  have  reported  on  the  outcomes  and
atient  satisfaction  with  individual  model  penile  prosthesis
mplantation.14--21 Patient  satisfaction  with  ED’s  treatment
s  often  accessed  through  either  a  visual  analog  scale  or
he  Erectile  Dysfunction  Inventory  of  Treatment  Satisfaction
EDITS)  questionnaire.
The  patient  version  of  the  EDITS  questionnaire  is  a
alidated  eleven  question  tool  to  access  overall  patient  sat-
sfaction  with  ED  treatment.22 As  previously  stated  it  has
een  thoroughly  used  in  the  past  to  access  patient  satis-
action  with  individual  penile  prothesis  models.  Frequently
odiﬁed  version  are  applied  where  original  questions  are
eplaced  by  treatment-speciﬁc  questions.21,23 When  inﬂat-
ble  penile  prothesis  are  concerned  EDITS  score  has  been Long-term  patient-reported  satisfaction  with  differ-
S  700CX  and  Coloplast  Titan.  Rev  Int  Androl.  2017.
how  to  rise  steady  until  at  least  one  year  after  surgery
hile  early  assessment  (three  and  six  months)  might  show
ess  satisfactory  results.24
 IN PRESS+Model
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Table  2  Patient’s  characteristics.
AMS
700CXTM
Titan
Coloplast
®
p
Number  of  patients  27  12
Age (years  ±  SD) 57.78  ±  8.51 61.48  ±  5.9 0.131
Preoperative  IIEF5 5.67  ±  0.87 5.67  ±  0.88 1.00
Median  follow  up
(months  ±  SD)
47.69  ±  16.96  82.83  ±  19.32  0.00
Postoperative
complication  (n)
0.006
Mechanical  failure  4  (33.3%)  1  (3.7%)
Etiology  (n)  0.674
Vasculogenic  2  (16.7%)  2  (7.4%)
Diabetes  mellitus  4  (33.3%)  8  (29.6%)
Radical  prostatectomy  4  (33.3%)  12  (44.4%)
Other  pelvic  surgery  1  (8.3%)  4  (14.8%)
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Comparison  between  AMS  700CX  and  Coloplast  Titan  
Although  there  are  several  studies  evaluating  patient,
partner  and  surgeon  satisfaction  as  well  as  speciﬁc  compo-
nents  and  technological  advances  of  a  single  model,  there
is  little  published  data  comparing  IPP  models.19,25 Currently,
IPP  model  selection  is  based  solely  on  pricing  and  surgeon
preference  disregarding  patient  satisfaction  or  preference.
The  main  aim  of  this  study  is  to  compare  overall  patient
satisfaction  after  implantation  of  either  AMS  700  CXTM or
Coloplast  Titan
®
IPP  for  the  treatment  of  ED.
Material and methods
After  obtaining  institutional  ethics  review  board  approval,
a  retrospective  study  was  conducted  between  January  2006
and  December  2014.  After  review  of  the  medical  records  a
total  of  55  men  submitted  to  either  AMS  700  CXTM or  Colo-
plast  Titan
®
IPP  implantation  who  could  potentially  meet  the
inclusion  and  exclusion  criteria  were  identiﬁed  (Table  1).
Data  regarding  patients’  demographics  and  preoperative
comorbid  conditions,  model  of  prosthesis  used,  peri  and
postoperative  complications  were  collected.  Patients  were
submitted  to  prothesis  implantation  through  a  standardized
penoscrotal  implant  technique  by  the  same  surgical  team
and  were  taught  how  to  operate  the  device  4--6  weeks  after
surgery  as  per  standardized  institution  protocol.  Thereafter
patients  were  followed  up  at  3  months,  6  months  and  once
a  year  thereafter.
Current  mechanical  status  of  the  prosthesis  and  patient
satisfaction  with  the  device  were  assessed  by  either  tele-
phone  or  face-to-face  interview,  according  to  each  patient’s
preference  after  informed  consent  was  obtained.  Patient
preoperative  erectile  function  was  accessed  through  the
validated  translated  version  of  the  briefed  International
Index  of  Erectile  Function  (IIEF-5).  Patient  satisfaction  was
evaluated  using  a  validated  version  of  Erectile  Dysfunction
Inventory  of  Treatment  Satisfaction  (EDITS)  questionnaire.
Questions  5  and  6  of  the  original  EDITS  were  not  included
as  they  were  not  appropriate  for  this  treatment.  Although
IIEF-5  was  also  applied  at  followup  results  are  not  shown  asPlease  cite  this  article  in  press  as:  Morgado  A,  et  al.
ent  inﬂatable  penile  prosthesis:  Comparison  between  AM
http://dx.doi.org/10.1016/j.androl.2017.07.003
question  2  to  4  was  always  5  and  both  questions  1  and  5
are  already  part  of  the  EDITS.  Statistical  analyses  were  per-
formed  using  SPSSTM 24.0  (IBM  SPSS  Inc.,  Chicago,  IL,  USA).
A  p  value  below  0.05  was  considered  signiﬁcant.  A  Student’s
Table  1  Inclusion  and  exclusion  criteria.  A  non-functional
penile  prosthesis  was  deﬁned  as  inability  to  fully  inﬂate  due
to mechanical  failure.
Inclusion  criteria
Acceptance  by  the  patient  and  informed  consent
Older than  18  years  old
Inﬂatable  penile  prothesis  model  either  AMS  700CXTM
or  Coloplast  Titan
®
Exclusion  criteria
A  non-functional  penile  prothesis  at  the  time  of  the  study
The inﬂatable  penile  prothesis  model  should  have  been
implanted  at  least  1  year  before  the  study
Lack of  stable  partner
New  onset  comorbidity  that  could  impair  penile  prothesis
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iPeyronie’s  disease  1  (8.3%)  1  (3.7%)
Abbreviations: SD, standard deviation.
-test  was  used  to  compare  samples  when  a  normal  distri-
ution  was  veriﬁed,  otherwise  a  Mann--Whitney  U  test  was
sed.  Chi-squared  was  used  to  access  sampling  distribution.
ultiple  regression  was  used  to  determine  if  the  observed
DITS  scores  could  be  predicted  by  patients  characteris-
ics  at  the  baseline,  postoperative  complications,  time  of
ollow-up  or  the  type  of  prosthesis  implanted.
esults
 total  of  55  men  that  underwent  penile  prothesis  implan-
ation  of  either  AMS  700  CXTM or  Coloplast  Titan
®
between
anuary  2006  and  December  2014  could  potentially  meet
he  inclusion  and  exclusion  criteria  (Table  1).  Thirty  nine
f  patients  accepted  to  answer  the  satisfaction  question-
aire,  13  patients  were  lost  to  follow-up  and  unreachable
hile  2  patients  were  deceased  resulting  in  a  response
ate  of  70.9%.  No  patient  refused  to  consent  and  par-
icipate.  A  total  of  27  and  12  patients  were  included  in
he  700CXTM and  Titan
®
group  respectively.  At  the  time  of
urgery,  the  median  age  ±  standard  deviation  (SD)  for  the
00CXTM patients  was  57.78  ±  8.51  years  whereas  it  was
1.48  ±  5.9  years  for  the  Titan® patients  and  median  follow-
p  times  was  47.69  ±  16.96  and  82.83  ±  19.32  months  for
ormer  and  latter  respectively.  The  mean  preoperative  IIEF-
 was  6.67  ±  0.83  versus  6.67  ±  0.88,  for  700CXTM and  Titan®
atients,  respectively.  There  was  no  statistically  signiﬁ-
ant  difference  in  age  (p  =  0.131),  yet  the  Titan
®
follow-up
as  longer  than  the  700CXTM (p  =  0.00).  There  were  more
ostoperative  complications  requiring  or  not  penile  pros-
hesis  revision  surgery  in  the  Coloplast  Titan
®
,  33.3%  versus
.7%  for  700CXTM (p  =  0.006).  Additional  variables  were  ana-
yzed  in  each  group  such  as  age,  body  mass  index,  relevant
edical  history  such  as  hypertension,  diabetes  mellitus,
islipidemia,  prior  pelvic  surgery,  prior  radiotherapy.  No Long-term  patient-reported  satisfaction  with  differ-
S  700CX  and  Coloplast  Titan.  Rev  Int  Androl.  2017.
tatistically  signiﬁcant  differences  were  found  between
roups  for  any  of  these  variables,  therefore  the  groups  were
ssumed  as  homogenous  regarding  demographic  character-
stics  (Table  2).
Please  cite  this  article  in  press  as:  Morgado  A,  et  al.  Long-term  patient-reported  satisfaction  with  differ-
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Table  3  EDITS  questionnaire  individual  questions  and  score.
EDITS  questions  AMS  700CXTMn  (%)  Titan  Coloplast
®
n  (%)  p
1.  Overall,  how  satisﬁed  are  you  with  this  treatment?  0.481
a. Very  satisﬁed 15  (55.6) 6  (50.0)
b. Somewhat  satisﬁed 9  (33.3) 4  (33.3)
c. Neither  satisﬁed  nor  dissatisﬁed  3  (11.1)  1  (8.3)
d. Somewhat  dissatisﬁed  0  (0)  1  (8.3)
e. Very  dissatisﬁed  0  (0)  0  (0)
2. During  the  past  four  weeks,  to  what  degree  has  the  treatment
met your  expectations?
0.920
a.  Completely  10  (37.0)  5  (41.7)
b. Considerably  12  (44.4)  4  (33.3)
c. Half  way  1  (3.7)  1  (8.3)
d. A  little  4  (14.8)  2  (16.7)
e. Not  at  all  0  (0)  0  (0)
3. How  likely  are  you  to  continue  using  this  treatment?  0.583
a. Very  likely  19  (70.4)  9  (75.0)
b. Moderately  likely  8  (29.6)  2  (16.7)
c. Neither  likely  nor  unlikely  0  (0)  0  (0)
d. Moderately  unlikely  0  (0)  1  (8.3)
e. Very  unlikely  0  (0)  0  (0)
4. During  the  past  four  weeks,  how  easy  was  it  for  you  to  use  this
treatment?
0.715
a. Very  easy  9  (33.3)  3  (25.0)
b. Moderately  easy  11  (40.7)  8  (66.7)
c. Neither  easy  nor  difﬁcult  7  (25.9)  1  (8.3)
d. Moderately  difﬁcult  0  (0)  0  (0)
e. Very  difﬁcult  0  (0)  0  (0)
7. How  conﬁdent  has  this  treatment  made  you  feel  about  your
ability to  engage  in  sexual  activity?
0.486
a.  Very  conﬁdent 12  (44.4) 3  (25.0)
b. Somewhat  conﬁdent 12  (44.4) 7  (58.3)
c. It  has  had  no  impact 3  (11.1) 1  (8.3)
d. Somewhat  less  conﬁdent  0  (0)  1  (8.3)
e. Very  much  less  conﬁdent  0  (0)  0  (0)
8. Overall,  how  satisﬁed  do  you  believe  your  partner  is  with  the
effects  of  this  treatment?
0.265
a.  Very  satisﬁed  6  (22.2)  2  (16.7)
b. Somewhat  satisﬁed  16  (59.3)  7  (58.3)
c. Neither  satisﬁed  nor  dissatisﬁed  4  (14.8)  0  (0)
d. Somewhat  dissatisﬁed  1  (3.7)  3  (25.0)
e. Very  dissatisﬁed  0  (0)  0  (0)
9. How  does  your  partner  feel  about  your  continuing  to  use  this
treatment?
0.536
a. My  partner  absolutely  wants  me  to  continue  16  (59.3)  9  (75.0)
b. My  partner  generally  prefers  me  to  continue  3  (11.1)  1  (8.3)
c. My  partner  has  no  opinion  8  (29.6)  1  (8.3)
d. My  partner  generally  prefers  me  to  stop  0  (0)  1  (8.3)
e. My  partner  absolutely  wants  me  to  stop  0  (0)  0  (0)
10. How  natural  did  the  process  of  achieving  an  erection  feel  when
you used  this  treatment  over  the  past  four  weeks?
0.958
a. Very  natural  7  (25.9)  2  (16.7)
b. Somewhat  natural  14  (51.9)  8  (66.7)
c. Neither  natural  nor  unnatural  1  (3.7)  0  (0)
d. Somewhat  unnatural  5  (18.5)  2  (16.7)
e. Very  unnatural  0  (0)  0  (0)
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Table  3  (Continued)
EDITS  questions  AMS  700CXTMn  (%)  Titan  Coloplast
®
n  (%)  p
11.  Compared  to  before  you  had  an  erection  problem  how  would  you
rate the  naturalness  of  your  erection  when  you  used  this  treatment
over the  past  four  weeks  in  terms  of  hardness?
0.245
a.  A  lot  harder  than  before  I  had  an  erection  problem  6  (22.2)  3  (25.0)
b. Somewhat  harder  than  before  I  had  an  erection  problem  8  (29.6)  6  (50.0)
c. The  same  hardness  as  before  I  had  an  erection  problem  6  (22.2)  2  (16.7)
d. Somewhat  less  hard  than  before  I  had  an  erection  problem 7  (25.9) 1  (8.3)
e. A  lot  less  hard  than  before  I  had  an  erection  problem 0  (0) 0  (0)
Mean EDITS  score  ±  SD 77.24  ±  12.14 77.54  ±  16.60 0.956
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(EDITS, Erectile Dysfunction Inventory of Treatment Satisfaction; S
The  patients’  overall  responses  to  the  EDITS  question-
naire  are  presented  in  Table  3.  Satisfaction,  as  assessed  by
EDITS  score,  was  not  different  between  700CXTM and  Titan
®
IPP  (77.2  ±  12.1  versus  77.5  ±  16.6  respectively,  p  =  0.956).
No  differences  were  found  regarding  fulﬁllment  of  expec-
tations,  will  to  continue  using  or  easiness  of  use  between
the  two  models.  There  were  mostly  positive  answers  in  all
individual  questions.  As  shown  by  multiple  regression,  the
age  at  the  time  of  the  surgery,  cause  of  ED,  preoperative
IIEF-5,  postoperative  complication,  follow-up  time  and  type
of  prosthesis  implanted  did  not  signiﬁcantly  inﬂuence  EDITS
scores  as  presented  in  Table  2.
There  were  no  statistically  signiﬁcant  differences  in  all
nine  individual  answers  of  EDITS  questionnaire  between
the  700CXTM and  Titan
®
IPP  groups.  The  overall  satisfac-
tion  rate  ±  SD  was  high  in  both  700CXTM and  Titan® groups,
77.24  ±  12.14  versus  77.54  ±  16.60  without  a  signiﬁcant  dif-
ference  between  them  (p  =  0.956).  As  shown  by  multiple
regression,  the  age  at  the  time  of  the  surgery,  cause  of
ED,  follow-up  time  and  type  of  prosthesis  implanted  did  not
signiﬁcantly  inﬂuence  EDITS  scores.
Discussion
To  our  current  knowledge  this  retrospective  comparison  has
the  longest  reported  follow  up  time.  It  is  also  one  of  the
fewest  intended  comparison  of  patient  overall  satisfaction
with  erectile  dysfunction  treatment  with  AMS  700CXTM and
Coloplast  Titan
®
IPP  models.
The  main  upside  of  our  study  is  the  long  follow  up  time
observed  as  a  mean  of  47.69  and  82.83  months  were  noted
for  both  700CXTM and  Titan
®
respectively.  Mulhall  et  al.
accessed  96  patients  sequentially  at  3,  6  and  12  months  after
penile  prothesis  implantation  using  EDITS.  As  patient  overall
satisfaction  was  signiﬁcantly  the  highest  at  12  months  they
reported  that  satisfaction  increases  in  year  1  after  implant
surgery  with  signiﬁcant  improvements  in  the  second  half  of
year  1.24 The  variability  of  patient  satisfaction  past  the  ﬁrst
postoperative  year  is  yet  to  be  evaluated.  Even  though  our
sample  is  relatively  small,  this  long  follow  up  period  pro-Please  cite  this  article  in  press  as:  Morgado  A,  et  al.
ent  inﬂatable  penile  prosthesis:  Comparison  between  AM
http://dx.doi.org/10.1016/j.androl.2017.07.003
vides  an  unique  look  toward  long  term  patient  satisfaction
with  both  700CXTM and  Titan
®
implantable  penile  prothesis
allowing  a  mature  comparison  and  excluding  potential  bias
from  a  the  postoperative  period  and  short  follow  up.
r
q
b
(andard deviation.
Contemporary  tree-piece  IPPs  models  are  consistently
ssociated  with  high  rates  of  patient  overall  satisfaction.
here  are  only  three  studies  comparing  AMS  700CXTM with
oloplast  Titan
®
implants  in  terms  of  patient  overall  satis-
action.  A  recent  study  from  Greece  was  conducted  in  90
atients  to  assess  the  patients’  erectile  function  and  sat-
sfaction  after  IPP  implantation  as  well  as  the  relationship
etween  patient  and  partner  satisfaction.25 Although  it  was
ot  speciﬁcally  designed  to  compare  different  types  of  pros-
hesis,  the  authors  reported  that  patient  satisfaction,  as
ssessed  by  EDITS  questionnaire,  did  not  differ  signiﬁcantly
etween  devices  implanted.  AMS  700CXTM and  Coloplast
itan
®
were  included  among  the  models  implanted.  Another
ecent  study  examined  the  clinical  outcomes  and  patient
atisfaction  in  138  men  with  coexisting  ED  and  Peyronie’s
isease  treated  with  either  Coloplast  Titan
®
or  AMS  700CXTM
PP.19 However,  only  a  visual  analog  scale  was  used  to  access
nd  compare  treatment  satisfaction  and  no  differences  were
oted.  More  recently,  Otero  et  al.  conducted  the  largest  ret-
ospective  study  with  248  patients  comparing  satisfaction
ith  either  AMS  700CXTM or  Coloplast  Titan
®
implantable
enile  prothesis  for  the  treatment  of  erectile  dysfunction.21
oncomitant  Peyronie’s  disease  or  previous  penile  surgery
ere  exclusion  factors.
As expected  there  was  a  high  satisfaction  with  penile
rothesis  implantation  on  both  groups.  Moreover,  there
ppear  to  be  no  signiﬁcant  difference  between  AMS  700CXTM
nd  Titan
®
groups  regarding  both  patient’s  satisfaction,  as
ssessed  by  EDITS’  question  1,  as  well  as  overall  satisfac-
ion,  as  assessed  through  the  ﬁnal  EDITS  score.  Moreover,
DITS  questions  answers  were  not  inﬂuenced  by  baseline
haracteristics  as  shown  by  multiple  regression  analysis.  As
reviously  stated,  Otero  et  al.  also  compared  the  afore-
entioned  models  in  248  patients  using  a  modiﬁed  non
alidated  EDITS  questionnaire  and  reported  that  there  were
ore  patients  satisﬁed  with  700CXTM. They  further  stated
hat  even  though  there  was  a  difference  in  satisfaction,
he  majority  of  patients  in  both  groups  had  positive  out-
uts  regarding  question  1.21 Indeed  they  noted  a  disparity
n  the  proportion  of  ‘‘very  satisﬁed’’  to  ‘‘satisﬁed’’  answers
70%  to  24%  versus  44%  to  44%  in  700CX  and  Titan
®
groups,
21 Long-term  patient-reported  satisfaction  with  differ-
S  700CX  and  Coloplast  Titan.  Rev  Int  Androl.  2017.
espectively). We  did  not  observe  such  a  difference  in
uestion  1  neither  there  was  a  so  signiﬁcant  disproportion
etween  ‘‘very  pleased’’  and  pleased’’  answers  in  700CXTM
50%  ‘‘very  pleased’’  to  33.3%  ‘‘pleased’’).
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Our  study  design  presents  some  limitations  from  its  ret-
ospective  design  as  well  as  lack  of  randomization  in  penile
rothesis  model  selection.  An  attrition  bias  is  highly  unlikely
s  stated  by  the  high  response  rate  (70.9%)  to  question-
aire  along  with  no  refusal  to  participate.  Patients  that
id  not  participate  were  either  deceased  or  unreachable
y  neither  phone  or  mail.  A  model  selection  bias  is  also
ighly  unlikely  as  inﬂatable  penile  prothesis  model  selec-
ion  was  restricted  by  hospital  adjudication  policies.  This
ack  of  randomization  or  even  surgeon  model  selection  led
o  signiﬁcant  differences  in  patient  follow  up  time,  although
ong  follow  ups  were  observed  in  both  groups.  Furthermore
here  is  no  evidence  that  IPP  model  selection  was  based
n  individual  patient  characteristics  which  could  jeopardize
ur  comparison  as  patient  demographics,  ED’s  etiology  and
omorbidities  were  not  different  between  groups.  Thus  sam-
les  were  considered  to  be  comparable.
In  the  future  meta-analysis  of  retrospective  comparisons
ike  ours  or  even  a  prospective  randomized  trial  might  con-
rm  or  refute  if  there  are  in  fact  no  differences  between
nﬂatable  penile  prothesis  models  when  patient  and  partner
verall  satisfaction  are  regarded.
The  two  most  used  three  piece  implantable  penile
rothesis  700CXTM and  Titan
®
do  not  have  signiﬁcant  over-
ll  patient  satisfaction  differences.  Moreover  there  were
lso  no  differences  noted  in  all  individual  questions  of
DITS  between  the  aforementioned  models.  Technically
oth  penile  prostheses  are  very  similar  in  their  design,  only
iffering  in  their  material  constituents  and  small  technical
etails  like  reservoir  shape  and  pump  mechanism.  This  dif-
erences  do  not  seem  to  lead  to  meaningful  differences  in
verall  patient  satisfaction  with  erectile  dysfunction  treat-
ent  with  either  three  piece  inﬂatable  penile  prothesis
odel.
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